Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/6/25 20:21 | 2/4/25 | TNGX | Health | Drug | Pharmaceutical Preparations | Barry Douglas | MA | O | GC | 1 | S.m | -16 | 3.07 | 0 | -5 | 66 | D | |||||||||||||||
2/6/25 20:10 | 2/4/25 | TNGX | Health | Drug | Pharmaceutical Preparations | Beckman Daniella | MA | O | CFO | 1 | S.m | -25 | 3.07 | 0 | -8 | 150 | D | |||||||||||||||
2/6/25 20:08 | 2/4/25 | TNGX | Health | Drug | Pharmaceutical Preparations | Crystal Adam | MA | O | See Rema | 1 | S.m | -44 | 3.07 | 0 | -14 | 158 | D | |||||||||||||||
2/6/25 20:02 | 2/4/25 | TNGX | Health | Drug | Pharmaceutical Preparations | Weber Barbara | MA | DO | CEO | 1 | S.m | -58 | 3.07 | 0 | -19 | 1,622 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |